Showing 37 to 43 of 43 results
Groundbreaking Clinical Trials Anticipated in 2025
In 2025, several groundbreaking clinical trials will release preliminary data, including a large-scale US dietary study employing AI analysis (8,000+ adults), Oxford University's CBD trial for psychosis (1,000 patients), and research on personalized cancer vaccines.
Groundbreaking Clinical Trials Anticipated in 2025
In 2025, several groundbreaking clinical trials will release preliminary data, including a large-scale US dietary study employing AI analysis (8,000+ adults), Oxford University's CBD trial for psychosis (1,000 patients), and research on personalized cancer vaccines.
Progress
12% Bias Score
2024's Top 5 Medical Breakthroughs: Gene Therapy, Xenotransplantation, and More
Five major medical breakthroughs in 2024 include gene therapy restoring hearing in deaf children, a pig kidney transplant for end-stage kidney disease, the discovery of a lupus cause and potential treatment, FDA approval of a new schizophrenia drug, and the first over-the-counter combination COVID-1...
2024's Top 5 Medical Breakthroughs: Gene Therapy, Xenotransplantation, and More
Five major medical breakthroughs in 2024 include gene therapy restoring hearing in deaf children, a pig kidney transplant for end-stage kidney disease, the discovery of a lupus cause and potential treatment, FDA approval of a new schizophrenia drug, and the first over-the-counter combination COVID-1...
Progress
20% Bias Score
VRTX Stock Surges on Positive Casgevy Data and Analyst Upgrades
Vertex Pharmaceuticals (VRTX) stock price is surging due to positive long-term data for its gene therapy Casgevy and several bullish analyst upgrades, with Jefferies raising its price target to $550.00.
VRTX Stock Surges on Positive Casgevy Data and Analyst Upgrades
Vertex Pharmaceuticals (VRTX) stock price is surging due to positive long-term data for its gene therapy Casgevy and several bullish analyst upgrades, with Jefferies raising its price target to $550.00.
Progress
52% Bias Score
Gene Therapy Breakthrough for Duchenne Muscular Dystrophy
A gene therapy developed by Généthon shows remarkable success in treating Duchenne muscular dystrophy in a young boy, offering hope for future treatments. Further research is underway.
Gene Therapy Breakthrough for Duchenne Muscular Dystrophy
A gene therapy developed by Généthon shows remarkable success in treating Duchenne muscular dystrophy in a young boy, offering hope for future treatments. Further research is underway.
Progress
0% Bias Score
AI-Powered Dietary Study to Reveal Personalized Weight Management Strategies in 2025
A major US study analyzing data from over 8,000 adults will publish initial results in early 2025, utilizing AI to analyze genetic factors, gut microbiome, lifestyle, and prior illnesses to improve predictions of individual responses to diets and long-term dietary changes.
AI-Powered Dietary Study to Reveal Personalized Weight Management Strategies in 2025
A major US study analyzing data from over 8,000 adults will publish initial results in early 2025, utilizing AI to analyze genetic factors, gut microbiome, lifestyle, and prior illnesses to improve predictions of individual responses to diets and long-term dietary changes.
Progress
40% Bias Score
Parents Sell Home to Fund Gene Therapy Research for Daughter with Ultra-Rare Disease
Tallulah Moon, a toddler from Australia, was misdiagnosed with leukodystrophy but later diagnosed with the ultra-rare SPG56; her parents are spearheading a $5 million gene therapy research project to find a cure, selling their home to fund part of the endeavor.
Parents Sell Home to Fund Gene Therapy Research for Daughter with Ultra-Rare Disease
Tallulah Moon, a toddler from Australia, was misdiagnosed with leukodystrophy but later diagnosed with the ultra-rare SPG56; her parents are spearheading a $5 million gene therapy research project to find a cure, selling their home to fund part of the endeavor.
Progress
16% Bias Score
Gene Therapy Shows Promise in Treating Fanconi Anemia
A Spanish-led team successfully used gene therapy to treat Fanconi anemia in nine children, achieving significant improvements and offering a safer alternative to bone marrow transplants.
Gene Therapy Shows Promise in Treating Fanconi Anemia
A Spanish-led team successfully used gene therapy to treat Fanconi anemia in nine children, achieving significant improvements and offering a safer alternative to bone marrow transplants.
Progress
16% Bias Score
Showing 37 to 43 of 43 results